Fig. 2From: Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinomaComprehensive landscape of RNA methylated modification writers in liver cancer. A The mutation frequency of RNA modification writers in liver cancer patients from the TCGA cohort. B GSEA elucidating the samples with or without writer mutation. C The mutation landscape of the RNA modification writers among pan-cancers in TCGA cohort. D Different CNV types of RNA modification writers in the TCGA-LIHC cohort. E The expression of RNA modification writers in paired normal and cancer tissues in TCGA-LIHC cohortBack to article page